BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,144,000 | -17.2% | 14,211 | -13.2% | 0.01% | -12.5% |
| Q1 2021 | $1,381,000 | -44.5% | 16,365 | -47.2% | 0.02% | -46.7% |
| Q4 2020 | $2,488,000 | +3.5% | 31,001 | +3.7% | 0.03% | -6.2% |
| Q3 2020 | $2,404,000 | -7.9% | 29,881 | -1.5% | 0.03% | -11.1% |
| Q2 2020 | $2,611,000 | -24.6% | 30,322 | -28.9% | 0.04% | -34.5% |
| Q1 2020 | $3,463,000 | -73.5% | 42,643 | -71.9% | 0.06% | -57.7% |
| Q4 2019 | $13,049,000 | +7.2% | 151,951 | +9.2% | 0.13% | -2.3% |
| Q3 2019 | $12,175,000 | +7.0% | 139,187 | +0.2% | 0.13% | +8.1% |
| Q2 2019 | $11,382,000 | -24.4% | 138,965 | -25.0% | 0.12% | -25.5% |
| Q1 2019 | $15,059,000 | +22.2% | 185,203 | -1.1% | 0.16% | +3.8% |
| Q4 2018 | $12,321,000 | -38.4% | 187,182 | -27.9% | 0.16% | -17.2% |
| Q3 2018 | $20,010,000 | +3.5% | 259,567 | -0.8% | 0.19% | +0.5% |
| Q2 2018 | $19,327,000 | +13.4% | 261,746 | -0.1% | 0.19% | +9.1% |
| Q1 2018 | $17,036,000 | +3.7% | 261,933 | +3.0% | 0.18% | +12.9% |
| Q4 2017 | $16,434,000 | +12.5% | 254,238 | +9.3% | 0.16% | +31.4% |
| Q3 2017 | $14,603,000 | +17.3% | 232,712 | +13.2% | 0.12% | +11.3% |
| Q2 2017 | $12,449,000 | +5.1% | 205,627 | -10.0% | 0.11% | +3.9% |
| Q1 2017 | $11,845,000 | -44.5% | 228,408 | -52.5% | 0.10% | -41.4% |
| Q4 2016 | $21,333,000 | -34.1% | 481,129 | -29.2% | 0.17% | -31.2% |
| Q3 2016 | $32,348,000 | +37.7% | 679,578 | +30.8% | 0.25% | +26.5% |
| Q2 2016 | $23,496,000 | +1291.1% | 519,598 | +1163.6% | 0.20% | +1150.0% |
| Q1 2016 | $1,689,000 | +27.1% | 41,119 | +18.0% | 0.02% | +23.1% |
| Q4 2015 | $1,329,000 | +18.3% | 34,846 | +2.0% | 0.01% | +8.3% |
| Q3 2015 | $1,123,000 | -56.7% | 34,178 | -7.9% | 0.01% | -62.5% |
| Q2 2015 | $2,595,000 | +175.2% | 37,113 | +169.8% | 0.03% | +190.9% |
| Q1 2015 | $943,000 | +9.7% | 13,757 | +17.3% | 0.01% | +10.0% |
| Q4 2014 | $860,000 | -36.3% | 11,731 | -37.7% | 0.01% | -72.2% |
| Q3 2014 | $1,350,000 | -8.1% | 18,815 | -7.4% | 0.04% | -7.7% |
| Q2 2014 | $1,469,000 | +58.0% | 20,315 | +60.6% | 0.04% | +39.3% |
| Q1 2014 | $930,000 | -19.2% | 12,653 | -23.6% | 0.03% | -36.4% |
| Q4 2013 | $1,151,000 | -9.2% | 16,553 | -14.0% | 0.04% | -20.0% |
| Q3 2013 | $1,267,000 | -25.6% | 19,253 | -19.4% | 0.06% | -8.3% |
| Q2 2013 | $1,702,000 | – | 23,900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |